Erratum to "A two-microRNA signature predicts the progression of male thyroid cancer".

Liu, Bingyang; Shi, Haihong; Qiu, Weigang; Wu, Xinquan; Li, Liqiong; Wu, Wenyi

Liu, Bingyang; Shi, Haihong; Qiu, Weigang; Wu, Xinquan; Li, Liqiong; Wu, Wenyi.

Afiliación

Liu B; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China.
Shi H; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China.
Qiu W; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China.
Wu X; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China.
Li L; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China.
Wu W; Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China.

Open Life Sci ; 17(1): 1116, 2022.

Article en En | MEDLINE | ID: mdl-36133423

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Life Sci Año: 2022 Tipo del documento: Article Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google